BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 1998
View Archived Issues
Association between plasma IGF-I and prostate cancer
Read More
Trimeris: Q4 and FY 1997 highlights
Read More
Immunex: FY 1997 highlights
Read More
SciClone: Q4 and FY 1997 highlights
Read More
ImmunoGen: Q2 1998 highlights
Read More
InSite Vision updates investors at H&Q conference
Read More
Company Profile: Alkermes
Read More
High in vivo efficacy of CS-834 in murine models of pneumonia
Read More
New water-soluble echinocandin compounds tested for efficacy in PCP
Read More
Clinical results of LHRH antagonist in BPH and prostate cancer
Read More
Canadian market introduction for Fraxiparine announced
Read More
Role of MK-991 in the treatment of histoplasmosis investigated
Read More
MMAS results discussed at world congress
Read More
Novel antidepressant completes phase I trials
Read More
Celtrix and Genzyme expand collaboration
Read More
Encouraging phase I results reported for Surfaxin in ARDS
Read More
Solvay and Elan to codevelop new formulation of fluvoxamine
Read More
FDA panel recommends approval for AcuTect
Read More
Positive preclinical results reported for IPL-423
Read More
Inex acquires antisense assets from Lynx
Read More
Quantison Depot renamed
Read More
FDA approves new dosage strength of Lodine XL
Read More
Faulding commences worldwide restructuring of operations
Read More
CytoGam overseas marketing expanded
Read More
Zoledronate compared to other bisphosphonates in rat models of bone loss
Read More
Promising results with AlloDerm reported
Read More
